SVT-15652 Otic Solution for the Treatment of Otomycosis

Summary

Multicenter, randomized, 2-arm parallel-group, double blind, placebo-controlled study in patients suffering from Otomycosis. This study will compare the efficacy and safety of SVT-15652 otic solution to that of Placebo, when administering one vial twice daily during 14 days.

Timeline

Start

2020-02-27

Primary completion

2021-10-25

Completion

2021-10-25

Drugs

Indications